InvestorsHub Logo
Followers 0
Posts 403
Boards Moderated 1
Alias Born 09/10/2014

Re: None

Thursday, 02/05/2015 1:10:01 PM

Thursday, February 05, 2015 1:10:01 PM

Post# of 39
Innovus Pharmaceuticals Enters $1 Billion Worldwide Nasal Steroid Market with the Acquisition of FlutiCare(TM) (Fluticasone Propionate Nasal) Over The Counter ("OTC") Rights from Novalere (OTCQB:INNV)

http://finance.yahoo.com/news/innovus-pharma-enters-1-billion-162000968.html

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.